Responsible for advising clinical trial sponsors and consults with regulatory authorities and industry organizations to advance the knowledge of eClinical and patient reported outcomes. A member of the core committee for the DIA’s Study Endpoints SIAC and the DIA Annual Meeting Program Committee.
Responsible for advising clinical trial sponsors and consults with regulatory authorities and industry organizations to advance the knowledge of eClinical and patient reported outcomes. A member of the core committee for the DIA’s Study Endpoints SIAC and the DIA Annual Meeting Program Committee.
Twelve years experience in the pharmaceutical industry, ranging from basic immunology research to scientific and operational aspects of clinical research and development. Holds an MPA in Health Policy and Management and a BS in Medical Laboratory Sciences. Leads an Informatics group at Merck.
Description
This symposium will present and discuss the key metrics that should be considered by sponsors to effectively monitor and manage the operational, financial and clinical progress of their clinical drug/device trials.
Learning Objectives: Recognize how metrics have progressed from past performance reporting to just-in-time surfacing of critical information Identify key categories of metrics that permit effective clinical trial study monitoring and management.